Doctors and Detailers: Therapeutic Education or Pharmaceutical Promotion?
暂无分享,去创建一个
[1] P R Manning,et al. How internists learned about cimetidine. , 1980, Annals of internal medicine.
[2] E. R. Peay,et al. Differences among practitioners in patterns of preference for information sources in the adoption of new drugs. , 1984, Social science & medicine.
[3] Russell R. Miller. Prescribing Habits of Physicians , 1973 .
[4] M. R. Ryan,et al. Pharmacist and physician evaluation of drug information sources. , 1975, American journal of hospital pharmacy.
[5] M. Rawlins. The role of the pharmaceutical industry in postgraduate medical education. , 1977, British journal of clinical pharmacology.
[6] E. Hemminki. Commercial Information on Drugs: Confusing the Physician? , 1988 .
[7] K. O'malley,et al. Drug promotion and the doctor. , 1982, British journal of clinical pharmacology.
[8] D. Burkholder. The Role of the Pharmaceutical Detailman in a Large Teaching Hospital , 1963 .
[9] M. Smith. Drug product advertising and prescribing: a review of the evidence. , 1977, American journal of hospital pharmacy.
[10] A. Wertheimer,et al. Sources of information and influence on new drug prescribing among physicians in an HMO. , 1979, Social science & medicine.
[11] B Strickland-Hodge,et al. Usage of Information Sources by General Practitioners1 , 1980, Journal of the Royal Society of Medicine.
[12] E. Hemminki. Content analysis of drug‐detailing by pharmaceutical representatives , 1977, Medical education.
[13] R Hartley,et al. Scientific versus commercial sources of influence on the prescribing behavior of physicians. , 1982, The American journal of medicine.
[14] R. W. Martin. Drug costs. , 1977, The New Zealand medical journal.
[15] E. R. Peay,et al. The role of commercial sources in the adoption of a new drug. , 1988, Social science & medicine.
[16] J. Banks,et al. Pattern of Prescribing in General Practice , 1963, British medical journal.
[17] L S Linn,et al. Physicians' orientation toward the legitimacy of drug use and their preferred source of new drug information. , 1972, Social science & medicine.
[18] C Bridges-Webb,et al. Use of sources of therapeutic and prescribing information by general practitioners. , 1980, Australian family physician.
[19] David Woods. PMAC to spend almost $1 million annually to reach “stakeholders” , 1986 .
[20] D. Worthen. Prescribing influences: an overview. , 1973, British journal of medical education.
[21] R. Bell,et al. The Compendium of Pharmaceuticals and Specialties: A Critical Analysis , 1983, International journal of health services : planning, administration, evaluation.
[22] R. Ogilvie,et al. Adverse drug reactions during hospitalization. , 1967, Canadian Medical Association journal.
[23] J D McCue,et al. Physicians' Opinions of the Accuracy, Accessibility, and Frequency of Use of Ten Sources of New Drug Information , 1986, Southern medical journal.
[24] David B. Montgomery,et al. Estimating Dynamic Effects of Market Communications Expenditures , 1972 .
[25] D. L. Sorby,et al. Physician attitudes toward drug information resources. , 1975, American journal of hospital pharmacy.
[26] G Eaton,et al. Sources of drug information used by general practitioners. , 1976, The Journal of the Royal College of General Practitioners.
[27] E. Hemminki,et al. The Effect of a Doctor's Personal Characteristics and Working Circumstances on the Prescribing of Psychotropic Drugs , 1974, Medical care.
[28] C. W. Gowdey,et al. Drug reactions and errors in administration on a medical ward. , 1967, Canadian Medical Association journal.
[29] W. Tester,et al. Dissemination of drug information. , 1968, Hospitals.
[30] D. Worthen. Prescribing influences: an overview 1 , 1973 .
[31] J. Banks,et al. The Drug House Representative , 1964 .
[32] C. M. Herman,et al. Communicating drug information to physicians. , 1976, Journal of medical education.
[33] J. Banks,et al. Influence of Different Sources of Therapeutic Information on Prescribing by General Practitioners , 1963, British medical journal.
[34] F Haayer,et al. Rational prescribing and sources of information. , 1982, Social science & medicine.
[35] Russell R. Miller. Prescribing Habits of Physicians: A Review of Studies on Prescribing of Drugs , 1973 .
[36] The Function of Drug Company Representatives , 1977, Scandinavian journal of social medicine.
[37] J P Gagnon,et al. Effects of promotion on pharmaceutical demand. , 1985, Social science & medicine.
[38] L Lasagna,et al. Differential education concerning therapeutics and resultant physician prescribing patterns. , 1972, Journal of medical education.
[39] R Mapes,et al. Aspects of British General Practitioners' Prescribing , 1977, Medical care.
[40] L. Krupka,et al. Prescription drug advertising: trends and implications. , 1985, Social science & medicine.
[41] J. Pekkanen. The Impact of Promotion on Physicians' Prescribing Patterns , 1976 .
[42] R. J. Meadows. Communicating New Drug Information — the Medium is the Message , 1981 .
[43] P M Williamson,et al. How general practitioners assess risks in using new drugs. , 1975, The Journal of the Royal College of General Practitioners.
[44] Leonard J. Parsons,et al. Analysis of Sales Call Effectiveness , 1981 .
[45] J. Boan,et al. Strained mercy : the economics of Canadian health care , 1985 .
[46] Raymond A. Bauer,et al. Doctor's Choice: The Physician and his Sources of Information about Drugs , 1966 .